CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
pelvic lymph node metastases in newly-diagnosed adult patients with prostate cancer and an intermediate to high risk for lymph node...
Phase 3
Berlin, Germany and 14 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Berlin, Germany and 388 other locations
to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...
Phase 3
Berlin, Germany and 322 other locations
hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...
Phase 3
Berlin, Germany and 272 other locations
Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...
Phase 3
Berlin, Germany and 258 other locations
The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA...
Phase 3
Berlin, Germany and 394 other locations
The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination...
Phase 3
Berlin, Germany and 313 other locations
or enzalutamide in participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) previously treated with one next-gener...
Phase 3
Berlin, Germany and 85 other locations
The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer....
Phase 3
Berlin, Germany and 397 other locations
The purpose of this study is to determine how participants with metastatic castration-resistant prostate cancer, and evidence of a ...
Phase 3
Berlin, Germany and 149 other locations
Clinical trials
Research sites
Resources
Legal